DNMT3A
9 abstracts
Abstract
A step toward genomic equity: Mutational profiling of patients with myeloid neoplasm in the largest minority-serving hospital in metropolitan Chicago.Org: John H. Stroger, Jr. Hospital of Cook County, Chicago, IL,
Abstract
Clonal hematopoiesis in survivors of childhood cancer.Org: New York City, St Louis, Washington University School of Medicine, ModernaTX, St. Louis,
Abstract
Outcome of TP53-mutated CCUS and the risk of progression to myeloid neoplasms.Org: Mayo Clinic, Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ,
Abstract
Clonal hematopoiesis (CH) associated mutations in patients with advanced solid tumors enrolled in phase I clinical trials.Org: Gustave Roussy Cancer Campus, Gustave Roussy Département d'Organisation du Parcours Patient, Paris Saclay University, Department of Biostatistics and Epidemiology, Department of Medical Biology and Pathology, Gustave Roussy, France, Paris,
Abstract
Methylation-based prediction of myelodysplastic syndrome survival outcomes.Org: GRAIL, LLC, a subsidiary of Illumina, Inc., Illumina, Inc., Columbia University - Mailman School of Public Health, Columbia University Medical Center,
Abstract
Outcomes of individuals with clonal hematopoiesis evaluated at a cancer center.Org: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Department of Biostatistics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan, Department of Hematopathology, Beijing Friendship Hospital, Capital Medical University,
Abstract
Homologous recombination-related (HRR) gene mutations in patients with glioma and their relevance to genomic characteristics, tumor mutation burden (TMB), and prognosis.Org: Jinan, China, Jiangsu Simcere Diagnostics Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., Nanjing Simcere Medical Laboratory Science Co., Ltd., The State Key Lab of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing, China,
Abstract
A survey on the detection of HPD-related genes by liquid biopsy in patients with lung cancer in China.Org: Tianjin Medical University General Hospital, Tianjin, China, HaploX Biotechnology, Shenzhen, China, HaploX Biotechnology Co. Ltd.,
Abstract
The genetics of transformation from myelodysplastic syndrome to secondary acute myeloid leukemia.Org: Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, Shandong, China, Shandong First Medical Universityand Shandong Academy of Medical Sciences, Sino-US Diagnostics Lab,